Generalized Cost-Effectiveness Analysis

Generalized Cost-Effectiveness Analysis (GCEA) Approach
The use of cost-effectiveness analysis within health decision making processes is increasingly common. However, a series of methodological shortcomings may limit the practical application of cost-effectiveness analysis results for deciding to reallocate resources between interventions to achieve social objectives. Two examples of this are methodological differences between studies that limit comparability, and use of the current practice as a comparator, which implicitly assumes current resource use is efficient. Generalized Cost-Effectiveness Analysis (GCEA) was developed to overcome such shortcomings of traditional cost-effectiveness analysis.
The GCEA approach enables both existing and new interventions to be evaluated simultaneously. The comparator used in GCEA is a hypothetical “null” scenario, where the impacts of all currently implemented interventions are removed. Uniquely, this method allows existing and new interventions to be analyzed at the same time. Using GCEA, the analyst is no longer constrained by what is already being done, and policymakers can revisit and revise past choices if necessary and feasible.
WHO-CHOICE
GCEA is part of the WHO-CHOICE project, which reports the costs and effects of a wide range of health interventions in the 14 demographic sub-regions of WHO (world divisions made based on geographical location and demographic profiles). The results of these cost-effectiveness analyses are assembled in sub-regional databases. This project uses a standardized method for cost effectiveness analysis that can be applied to all interventions across health sectors and in different settings.
The tools required to assess intervention costs and impacts at the population level are available for use at country level and the CHOICE team is available to assist policy makers and other stakeholders to interpret and use the evidence.
External Publications
All →
The global landscape of country-level health technology assessment processes: A survey among 104 countries
To assess the practice of HTA in countries, WHO conducted a global survey that explores the status of HTA. The survey is the largest source of information...

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income...
Most individuals developing tuberculosis (TB) are working age adults living in low- and middle-income countries (LMICs). The resulting disability and death...

The Macroeconomic Impact of Increasing Investments in Malaria Control in 26 High Malaria Burden Countries:...
Malaria remains a major public health problem. While globally malaria mortality affects predominantly young children, clinical malaria affects all age...
Frequently asked questions
Related health topics
Contact Us
If you have a query or feedback please contact